[RUN_AMAF] provider=lambda | model=deepseek-r1-671b
DEBUG: Initializing agent TabuSynth with provider=lambda, model=deepseek-r1-671b
DEBUG: Initializing agent Contextron with provider=lambda, model=deepseek-r1-671b
DEBUG: Initializing agent Visura with provider=lambda, model=deepseek-r1-671b
DEBUG: Initializing agent SummaCraft with provider=lambda, model=deepseek-r1-671b
DEBUG: Initializing agent TrendAnalyser with provider=lambda, model=deepseek-r1-671b
DEBUG: Initializing agent MCP with provider=lambda, model=deepseek-r1-671b
DEBUG: _chat called with provider=lambda, model=deepseek-r1-671b
DEBUG: Using OpenAI client.chat.completions.create() with model=deepseek-r1-671b
DEBUG: OpenAI API call successful, response type: <class 'openai.types.chat.chat_completion.ChatCompletion'>
DEBUG: _chat called with provider=lambda, model=deepseek-r1-671b
DEBUG: Using OpenAI client.chat.completions.create() with model=deepseek-r1-671b
DEBUG: OpenAI API call successful, response type: <class 'openai.types.chat.chat_completion.ChatCompletion'>
DEBUG: _chat called with provider=lambda, model=deepseek-r1-671b
DEBUG: Using OpenAI client.chat.completions.create() with model=deepseek-r1-671b
DEBUG: OpenAI API call successful, response type: <class 'openai.types.chat.chat_completion.ChatCompletion'>

=== FINAL SUMMARY ===

{
  "1c7f7554-6c99-4894-8685-3ecb57a3ee73": [
    "Deferred costs are amortised on a straight-line basis from the date of commercial release.",
    ""
  ],
  "ec690932-9852-4987-9e84-e4728ed6ca43": [
    [
      "2",
      "10"
    ],
    ""
  ],
  "1622dca1-ac9d-404e-b621-8b1fb02c2350": [
    [
      "2019",
      "2018"
    ],
    ""
  ],
  "070a9fb1-6d17-40ba-b34e-82d0fe14037b": [
    "3.85",
    "percent"
  ],
  "a8a7c154-567e-4b21-878e-85dab9d28fc9": [
    "20.60",
    "percent"
  ],
  "9fce8f25-dd3b-4c50-9b7b-d200ced15ded": [
    "222.58",
    "percent"
  ]
}

=== LOGS (per-agent) ===
{'TabuSynth': {'cot': '**QID: 1c7f7554-6c99-4894-8685-3ecb57a3ee73 - How are '
                      'the deferred costs amortised?**  \n'
                      '- **Answer**: The table does not contain information '
                      'about deferred cost amortization methods.  \n'
                      '- **Evidence**: No rows in the table mention "deferred '
                      'costs" or "amortization."  \n'
                      '- **Table Data Used**: None  \n'
                      '- **Missing Information**: Details about amortization '
                      'policies or deferred cost accounting methods.  \n'
                      '\n'
                      '---\n'
                      '\n'
                      '**QID: ec690932-9852-4987-9e84-e4728ed6ca43 - How long '
                      'is the period of expected benefit?**  \n'
                      '- **Answer**: The table does not specify the period of '
                      'expected benefit for any costs.  \n'
                      '- **Evidence**: No rows reference amortization periods, '
                      'capitalization periods, or benefit durations.  \n'
                      '- **Table Data Used**: None  \n'
                      '- **Missing Information**: Timeframes for cost '
                      'capitalization or benefit periods.  \n'
                      '\n'
                      '---\n'
                      '\n'
                      '**QID: 1622dca1-ac9d-404e-b621-8b1fb02c2350 - What are '
                      'the years included in the table?**  \n'
                      '- **Answer**: ["2019", "2018"]  \n'
                      '- **Evidence**: Column headers in row 2 (0-based '
                      'index).  \n'
                      '- **Table Data Used**: Row 2, Columns 1 and 2  \n'
                      '- **Missing Information**: None  \n'
                      '\n'
                      '---\n'
                      '\n'
                      '**QID: 070a9fb1-6d17-40ba-b34e-82d0fe14037b - What is '
                      'the percentage change in the research and development '
                      'costs incurred from 2018 to 2019?**  \n'
                      '- **Answer**: 3.85% (increase)  \n'
                      '- **Evidence**:  \n'
                      '  - 2018 value: 17,793 (Row 18, Column 2)  \n'
                      '  - 2019 value: 18,478 (Row 18, Column 1)  \n'
                      '  - Calculation: ((18,478 - 17,793) / 17,793) × 100 ≈ '
                      '3.85%  \n'
                      '- **Table Data Used**: Row 18, Columns 1 and 2  \n'
                      '- **Missing Information**: None  \n'
                      '\n'
                      '---\n'
                      '\n'
                      '**QID: a8a7c154-567e-4b21-878e-85dab9d28fc9 - What is '
                      'the percentage change in the total expense relating to '
                      'operating leases from 2018 to 2019?**  \n'
                      '- **Answer**: 20.60% (increase)  \n'
                      '- **Evidence**:  \n'
                      '  - 2018 value: 3,650 (Row 14, Column 2)  \n'
                      '  - 2019 value: 4,402 (Row 14, Column 1)  \n'
                      '  - Calculation: ((4,402 - 3,650) / 3,650) × 100 ≈ '
                      '20.60%  \n'
                      '- **Table Data Used**: Row 14, Columns 1 and 2  \n'
                      '- **Missing Information**: None  \n'
                      '\n'
                      '---\n'
                      '\n'
                      '**QID: 9fce8f25-dd3b-4c50-9b7b-d200ced15ded - What is '
                      'the percentage change in the finance costs expensed '
                      'from 2018 to 2019?**  \n'
                      '- **Answer**: 222.58% (increase)  \n'
                      '- **Evidence**:  \n'
                      '  - 2018 value: 62 (Row 9, Column 2)  \n'
                      '  - 2019 value: 200 (Row 9, Column 1)  \n'
                      '  - Calculation: ((200 - 62) / 62) × 100 ≈ 222.58%  \n'
                      '- **Table Data Used**: Row 9, Columns 1 and 2  \n'
                      '- **Missing Information**: None',
               'result': '**QID: 1c7f7554-6c99-4894-8685-3ecb57a3ee73 - How '
                         'are the deferred costs amortised?**  \n'
                         '- **Answer**: The table does not contain information '
                         'about deferred cost amortization methods.  \n'
                         '- **Evidence**: No rows in the table mention '
                         '"deferred costs" or "amortization."  \n'
                         '- **Table Data Used**: None  \n'
                         '- **Missing Information**: Details about '
                         'amortization policies or deferred cost accounting '
                         'methods.  \n'
                         '\n'
                         '---\n'
                         '\n'
                         '**QID: ec690932-9852-4987-9e84-e4728ed6ca43 - How '
                         'long is the period of expected benefit?**  \n'
                         '- **Answer**: The table does not specify the period '
                         'of expected benefit for any costs.  \n'
                         '- **Evidence**: No rows reference amortization '
                         'periods, capitalization periods, or benefit '
                         'durations.  \n'
                         '- **Table Data Used**: None  \n'
                         '- **Missing Information**: Timeframes for cost '
                         'capitalization or benefit periods.  \n'
                         '\n'
                         '---\n'
                         '\n'
                         '**QID: 1622dca1-ac9d-404e-b621-8b1fb02c2350 - What '
                         'are the years included in the table?**  \n'
                         '- **Answer**: ["2019", "2018"]  \n'
                         '- **Evidence**: Column headers in row 2 (0-based '
                         'index).  \n'
                         '- **Table Data Used**: Row 2, Columns 1 and 2  \n'
                         '- **Missing Information**: None  \n'
                         '\n'
                         '---\n'
                         '\n'
                         '**QID: 070a9fb1-6d17-40ba-b34e-82d0fe14037b - What '
                         'is the percentage change in the research and '
                         'development costs incurred from 2018 to 2019?**  \n'
                         '- **Answer**: 3.85% (increase)  \n'
                         '- **Evidence**:  \n'
                         '  - 2018 value: 17,793 (Row 18, Column 2)  \n'
                         '  - 2019 value: 18,478 (Row 18, Column 1)  \n'
                         '  - Calculation: ((18,478 - 17,793) / 17,793) × 100 '
                         '≈ 3.85%  \n'
                         '- **Table Data Used**: Row 18, Columns 1 and 2  \n'
                         '- **Missing Information**: None  \n'
                         '\n'
                         '---\n'
                         '\n'
                         '**QID: a8a7c154-567e-4b21-878e-85dab9d28fc9 - What '
                         'is the percentage change in the total expense '
                         'relating to operating leases from 2018 to 2019?**  \n'
                         '- **Answer**: 20.60% (increase)  \n'
                         '- **Evidence**:  \n'
                         '  - 2018 value: 3,650 (Row 14, Column 2)  \n'
                         '  - 2019 value: 4,402 (Row 14, Column 1)  \n'
                         '  - Calculation: ((4,402 - 3,650) / 3,650) × 100 ≈ '
                         '20.60%  \n'
                         '- **Table Data Used**: Row 14, Columns 1 and 2  \n'
                         '- **Missing Information**: None  \n'
                         '\n'
                         '---\n'
                         '\n'
                         '**QID: 9fce8f25-dd3b-4c50-9b7b-d200ced15ded - What '
                         'is the percentage change in the finance costs '
                         'expensed from 2018 to 2019?**  \n'
                         '- **Answer**: 222.58% (increase)  \n'
                         '- **Evidence**:  \n'
                         '  - 2018 value: 62 (Row 9, Column 2)  \n'
                         '  - 2019 value: 200 (Row 9, Column 1)  \n'
                         '  - Calculation: ((200 - 62) / 62) × 100 ≈ '
                         '222.58%  \n'
                         '- **Table Data Used**: Row 9, Columns 1 and 2  \n'
                         '- **Missing Information**: None',
               'raw': '**QID: 1c7f7554-6c99-4894-8685-3ecb57a3ee73 - How are '
                      'the deferred costs amortised?**  \n'
                      '- **Answer**: The table does not contain information '
                      'about deferred cost amortization methods.  \n'
                      '- **Evidence**: No rows in the table mention "deferred '
                      'costs" or "amortization."  \n'
                      '- **Table Data Used**: None  \n'
                      '- **Missing Information**: Details about amortization '
                      'policies or deferred cost accounting methods.  \n'
                      '\n'
                      '---\n'
                      '\n'
                      '**QID: ec690932-9852-4987-9e84-e4728ed6ca43 - How long '
                      'is the period of expected benefit?**  \n'
                      '- **Answer**: The table does not specify the period of '
                      'expected benefit for any costs.  \n'
                      '- **Evidence**: No rows reference amortization periods, '
                      'capitalization periods, or benefit durations.  \n'
                      '- **Table Data Used**: None  \n'
                      '- **Missing Information**: Timeframes for cost '
                      'capitalization or benefit periods.  \n'
                      '\n'
                      '---\n'
                      '\n'
                      '**QID: 1622dca1-ac9d-404e-b621-8b1fb02c2350 - What are '
                      'the years included in the table?**  \n'
                      '- **Answer**: ["2019", "2018"]  \n'
                      '- **Evidence**: Column headers in row 2 (0-based '
                      'index).  \n'
                      '- **Table Data Used**: Row 2, Columns 1 and 2  \n'
                      '- **Missing Information**: None  \n'
                      '\n'
                      '---\n'
                      '\n'
                      '**QID: 070a9fb1-6d17-40ba-b34e-82d0fe14037b - What is '
                      'the percentage change in the research and development '
                      'costs incurred from 2018 to 2019?**  \n'
                      '- **Answer**: 3.85% (increase)  \n'
                      '- **Evidence**:  \n'
                      '  - 2018 value: 17,793 (Row 18, Column 2)  \n'
                      '  - 2019 value: 18,478 (Row 18, Column 1)  \n'
                      '  - Calculation: ((18,478 - 17,793) / 17,793) × 100 ≈ '
                      '3.85%  \n'
                      '- **Table Data Used**: Row 18, Columns 1 and 2  \n'
                      '- **Missing Information**: None  \n'
                      '\n'
                      '---\n'
                      '\n'
                      '**QID: a8a7c154-567e-4b21-878e-85dab9d28fc9 - What is '
                      'the percentage change in the total expense relating to '
                      'operating leases from 2018 to 2019?**  \n'
                      '- **Answer**: 20.60% (increase)  \n'
                      '- **Evidence**:  \n'
                      '  - 2018 value: 3,650 (Row 14, Column 2)  \n'
                      '  - 2019 value: 4,402 (Row 14, Column 1)  \n'
                      '  - Calculation: ((4,402 - 3,650) / 3,650) × 100 ≈ '
                      '20.60%  \n'
                      '- **Table Data Used**: Row 14, Columns 1 and 2  \n'
                      '- **Missing Information**: None  \n'
                      '\n'
                      '---\n'
                      '\n'
                      '**QID: 9fce8f25-dd3b-4c50-9b7b-d200ced15ded - What is '
                      'the percentage change in the finance costs expensed '
                      'from 2018 to 2019?**  \n'
                      '- **Answer**: 222.58% (increase)  \n'
                      '- **Evidence**:  \n'
                      '  - 2018 value: 62 (Row 9, Column 2)  \n'
                      '  - 2019 value: 200 (Row 9, Column 1)  \n'
                      '  - Calculation: ((200 - 62) / 62) × 100 ≈ 222.58%  \n'
                      '- **Table Data Used**: Row 9, Columns 1 and 2  \n'
                      '- **Missing Information**: None'},
 'Contextron': {'cot': '**Question 1c7f7554-6c99-4894-8685-3ecb57a3ee73**: How '
                       'are the deferred costs amortised?  \n'
                       '**Answer**: Deferred costs are amortised on a '
                       'straight-line basis from the date of commercial '
                       'release.  \n'
                       '**Source**: text  \n'
                       '**Type**: span',
                'result': '**Question ec690932-9852-4987-9e84-e4728ed6ca43**: '
                          'How long is the period of expected benefit?  \n'
                          '**Answer**: ["2", "10"]  \n'
                          '**Source**: text  \n'
                          '**Type**: multi-span  \n'
                          '\n'
                          '**Question 1622dca1-ac9d-404e-b621-8b1fb02c2350**: '
                          'What are the years included in the table?  \n'
                          '**Answer**: ["2019", "2018"]  \n'
                          '**Source**: table  \n'
                          '**Type**: multi-span  \n'
                          '\n'
                          '**Question 070a9fb1-6d17-40ba-b34e-82d0fe14037b**: '
                          'What is the percentage change in the research and '
                          'development costs incurred from 2018 to 2019?  \n'
                          '**Answer**: 3.85% (increase)  \n'
                          '**Source**: table  \n'
                          '**Type**: arithmetic  \n'
                          '\n'
                          '**Question a8a7c154-567e-4b21-878e-85dab9d28fc9**: '
                          'What is the percentage change in the total expense '
                          'relating to operating leases from 2018 to 2019?  \n'
                          '**Answer**: 20.60% (increase)  \n'
                          '**Source**: table  \n'
                          '**Type**: arithmetic  \n'
                          '\n'
                          '**Question 9fce8f25-dd3b-4c50-9b7b-d200ced15ded**: '
                          'What is the percentage change in the finance costs '
                          'expensed from 2018 to 2019?  \n'
                          '**Answer**: 222.58% (increase)  \n'
                          '**Source**: table  \n'
                          '**Type**: arithmetic  \n'
                          '\n'
                          '---\n'
                          '\n'
                          '**Textual Context Summary**:  \n'
                          'The text outlines accounting policies for '
                          'expenses:  \n'
                          '1. Operating lease costs are recognized on a '
                          'straight-line basis over the lease term.  \n'
                          '2. Finance costs are expensed in the period '
                          'incurred.  \n'
                          '3. Research costs are expensed immediately; '
                          'development costs may be deferred if linked to '
                          'viable technology.  \n'
                          '4. Deferred costs (directly attributable expenses) '
                          'are amortized straight-line over 2-10 years from '
                          'commercial release.  \n'
                          'Key concepts: Straight-line amortization, expense '
                          'timing, R&D capitalization criteria.',
                'raw': '**Question 1c7f7554-6c99-4894-8685-3ecb57a3ee73**: How '
                       'are the deferred costs amortised?  \n'
                       '**Answer**: Deferred costs are amortised on a '
                       'straight-line basis from the date of commercial '
                       'release.  \n'
                       '**Source**: text  \n'
                       '**Type**: span  \n'
                       '\n'
                       '**Question ec690932-9852-4987-9e84-e4728ed6ca43**: How '
                       'long is the period of expected benefit?  \n'
                       '**Answer**: ["2", "10"]  \n'
                       '**Source**: text  \n'
                       '**Type**: multi-span  \n'
                       '\n'
                       '**Question 1622dca1-ac9d-404e-b621-8b1fb02c2350**: '
                       'What are the years included in the table?  \n'
                       '**Answer**: ["2019", "2018"]  \n'
                       '**Source**: table  \n'
                       '**Type**: multi-span  \n'
                       '\n'
                       '**Question 070a9fb1-6d17-40ba-b34e-82d0fe14037b**: '
                       'What is the percentage change in the research and '
                       'development costs incurred from 2018 to 2019?  \n'
                       '**Answer**: 3.85% (increase)  \n'
                       '**Source**: table  \n'
                       '**Type**: arithmetic  \n'
                       '\n'
                       '**Question a8a7c154-567e-4b21-878e-85dab9d28fc9**: '
                       'What is the percentage change in the total expense '
                       'relating to operating leases from 2018 to 2019?  \n'
                       '**Answer**: 20.60% (increase)  \n'
                       '**Source**: table  \n'
                       '**Type**: arithmetic  \n'
                       '\n'
                       '**Question 9fce8f25-dd3b-4c50-9b7b-d200ced15ded**: '
                       'What is the percentage change in the finance costs '
                       'expensed from 2018 to 2019?  \n'
                       '**Answer**: 222.58% (increase)  \n'
                       '**Source**: table  \n'
                       '**Type**: arithmetic  \n'
                       '\n'
                       '---\n'
                       '\n'
                       '**Textual Context Summary**:  \n'
                       'The text outlines accounting policies for expenses:  \n'
                       '1. Operating lease costs are recognized on a '
                       'straight-line basis over the lease term.  \n'
                       '2. Finance costs are expensed in the period '
                       'incurred.  \n'
                       '3. Research costs are expensed immediately; '
                       'development costs may be deferred if linked to viable '
                       'technology.  \n'
                       '4. Deferred costs (directly attributable expenses) are '
                       'amortized straight-line over 2-10 years from '
                       'commercial release.  \n'
                       'Key concepts: Straight-line amortization, expense '
                       'timing, R&D capitalization criteria.'},
 'SummaCraft': {'cot': '(omitted)',
                'result': '{\n'
                          '  "1c7f7554-6c99-4894-8685-3ecb57a3ee73": [\n'
                          '    "Deferred costs are amortised on a '
                          'straight-line basis from the date of commercial '
                          'release.",\n'
                          '    ""\n'
                          '  ],\n'
                          '  "ec690932-9852-4987-9e84-e4728ed6ca43": [\n'
                          '    [\n'
                          '      "2",\n'
                          '      "10"\n'
                          '    ],\n'
                          '    ""\n'
                          '  ],\n'
                          '  "1622dca1-ac9d-404e-b621-8b1fb02c2350": [\n'
                          '    [\n'
                          '      "2019",\n'
                          '      "2018"\n'
                          '    ],\n'
                          '    ""\n'
                          '  ],\n'
                          '  "070a9fb1-6d17-40ba-b34e-82d0fe14037b": [\n'
                          '    "3.85",\n'
                          '    "percent"\n'
                          '  ],\n'
                          '  "a8a7c154-567e-4b21-878e-85dab9d28fc9": [\n'
                          '    "20.60",\n'
                          '    "percent"\n'
                          '  ],\n'
                          '  "9fce8f25-dd3b-4c50-9b7b-d200ced15ded": [\n'
                          '    "222.58",\n'
                          '    "percent"\n'
                          '  ]\n'
                          '}',
                'raw': '```json\n'
                       '{\n'
                       '  "1c7f7554-6c99-4894-8685-3ecb57a3ee73": ["Deferred '
                       'costs are amortised on a straight-line basis from the '
                       'date of commercial release.", ""],\n'
                       '  "ec690932-9852-4987-9e84-e4728ed6ca43": [["2", '
                       '"10"], ""],\n'
                       '  "1622dca1-ac9d-404e-b621-8b1fb02c2350": [["2019", '
                       '"2018"], ""],\n'
                       '  "070a9fb1-6d17-40ba-b34e-82d0fe14037b": ["3.85", '
                       '"percent"],\n'
                       '  "a8a7c154-567e-4b21-878e-85dab9d28fc9": ["20.60", '
                       '"percent"],\n'
                       '  "9fce8f25-dd3b-4c50-9b7b-d200ced15ded": ["222.58", '
                       '"percent"]\n'
                       '}\n'
                       '```'}}
